MedPath

Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)

Not Applicable
Completed
Conditions
Delirium
Interventions
Behavioral: HELP Support System
Behavioral: Family Support System
Registration Number
NCT04007523
Lead Sponsor
University of Michigan
Brief Summary

This is a pilot randomized controlled trial that will test whether a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Decision support systems will be tested that provide targeted alerts and recommendations to the Hospital Elder Life Program and family members for delirium prevention.

Detailed Description

Delirium is a distressing and common surgical complication, affecting approximately 20-50% of older surgical patients. Postoperative delirium is associated with increased mortality, cognitive and functional decline, and healthcare resource utilization. Prevention programs have been tested with variable success, but the Hospital Elder Life Program (HELP) has consistently been demonstrated to reduce the incidence and impact of delirium. However, substantial resources are needed for program operations, and complementary support systems may help with patient triage and assessment. Family members and caretakers may be able to provide supplementary support with delirium screening and prevention via targeted, therapeutic activities. Thus, an automated postoperative paging system, which elicits additional, focused support from HELP and family members, may augment delirium prevention activities and reduce associated risk.

The primary objectives of this study are to determine whether pager-based clinical decision support systems bolster HELP- and family-based therapeutic activities. A secondary objective will be to identify facilitators and barriers to delivering therapeutic interventions for both HELP and family members. Overall, this pilot trial will test the hypothesis that a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Patients (n=60) will be randomized to one of four groups in a factorial design: usual care (n=15), HELP-based paging system (n=15), family-based paging system (n=15), or both HELP- and family-based paging system (n=15). The support systems will consist of automated pager alerts to the HELP program and/or family members and caretakers, depending on group allocation, for providing additional delirium evaluation and therapeutic prevention activities. Outcomes will include various clinical, neurocognitive, and functional measures, and performance metrics will be collected regarding HELP- and family-based interventions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age ≥ 70 years of age
  • Major non-cardiac, non-intracranial neurologic, and non-major vascular surgery
  • Anticipated length of stay at least 72 hours
  • At least one family member, or caretaker, available on each of the first three postoperative days for trial operations
Read More
Exclusion Criteria
  • Emergency surgery
  • Severe cognitive impairment (precluding ability to perform delirium assessments)
  • Planned postoperative ICU admission
  • Non-English speaking
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
HELP Support SystemHELP Support SystemThis arm will receive the HELP Support System intervention only
Family Support SystemFamily Support SystemThis arm will receive the Family Support system intervention only
Combined Support SystemsFamily Support SystemParticipants randomized to this arm will receive both HELP- and family-based support system interventions
Combined Support SystemsHELP Support SystemParticipants randomized to this arm will receive both HELP- and family-based support system interventions
Primary Outcome Measures
NameTimeMethod
Deliriummorning postoperative day one through afternoon of postoperative day three

Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (n, 0-19)

Secondary Outcome Measures
NameTimeMethod
Depressive Symptoms as Assessed by Hospitalized Anxiety and Depression Scale (HADS-D)baseline through postoperative day 2

Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)

Discharge Dispositionday of hospital discharge, up to 30 days

Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility), up to 30 days

Delayed Discharge - Cognitive Impairmentday of hospital discharge, up to 30 days

Proportion of patients in each group (%) experiencing delayed discharge, with the documented reason as cognitive impairment

Delirium Severitymorning postoperative day one through afternoon of postoperative day three

For any patient with a completed delirium assessment, the associated severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (n, 0-19, with higher number indicating more severe delirium)

Anxiety Symptoms as Assessed by Hospitalized Anxiety and Depression Scale (HADS-A)baseline through postoperative day 3

Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)

Fallsmorning postoperative day one through afternoon of postoperative day three

Proportion of patients in each group (%) experiencing at least one fall

Length of Hospital Staymorning of surgery until day of hospital discharge, up to 30 days

Total number of days (n) spent in the hospital, up to 30 days

New Non-surgical Site Infectionmorning of surgery until day of hospital discharge, up to 30 days

Incidence (%) of any new non-surgical site infection while hospitalized

Multidrug Resistant Organism Colonizationmorning postoperative day one through 30 days after surgery

Incidence (%) of any new multidrug resistant organism colonization

Mortalitywithin 30 days after surgery

Incidence (%)

Trial Locations

Locations (1)

University of Michigan Medical School

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath